Search for: "In re David C." Results 1 - 20 of 2,536
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 May 2024, 5:45 am by Norman L. Eisen
Last week, both the prosecution and the defense rested their cases in former President Donald Trump’s New York trial for allegedly falsifying business records (FBR) in his effort “to unlawfully influence the 2016 presidential election,” in the words of Manhattan Supreme Court Justice Juan Merchan’s case summary. [read post]
17 May 2024, 4:43 am by Matthias Weller
Scotland, Northern Ireland), but is rather subject to re-examination by the competent court (e.g. [read post]
14 May 2024, 6:46 am by David Pocklington
Note A timeline of reports &c relating to John Smyth, from 2017 to present, is in our post  John Smyth: A timeline. [read post]
26 Apr 2024, 3:00 am by Jim Sedor
Intensifies Scrutiny of Voting: ‘We’re keeping a close eye on you’ DNyuz – Nick Corasaniti, Alexandra Berzon, and Michael Gold (New York Times) | Published: 4/20/2024 Donald Trump’s campaign and the Republican National Committee plan to dispatch more than 100,000 volunteers and lawyers to monitor and potentially challenge the electoral process in each battleground state. [read post]
22 Apr 2024, 5:00 am by Bernard Bell
Many state and local officials host social media sites and use them to converse with followers on matters related to their governmental responsibilities, among other things.[1]  Not surprisingly, many choose to block from their sites certain members of the public they find disagreeable.[2] Being disagreeable, or at least in disagreement with such actions, blocked followers sometimes sue alleging that their exclusion violates the First Amendment.[3]  One of the most notable examples was a… [read post]
19 Apr 2024, 9:27 am by CFM Admin
Additionally, we’re pleased to welcome Afruz Sayah as an Associate and Stephanie Cepeda as a Paralegal for the Corporate and Transactional practice group. [read post]
19 Apr 2024, 3:00 am by Jim Sedor
Supreme Court Weighs New Bribery Case as More Clashes Are Brewing MSN – Jan Wolfe and C. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
8 Apr 2024, 10:08 am by admin
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]
3 Apr 2024, 4:08 pm by admin
Re-analyses can be important, but these reanalyses of published Bendectin studies were post hoc, litigation driven, and obviously result oriented. [read post]